Two US scientists awarded Balzan Prize for cancer research

September 11, 2017 by Colleen Barry
Salvatore Veca attends a press conference to present a 2017 Balzan's prize edition, in Milan, Italy, Monday, Sept. 11, 2017. James Allison of the University of Texas MD Anderson Cancer Center and Robert Schreiber of the Washington School of Medicine were announced Monday as winners of the 750,000 Swiss franc (660,000 euro, $790,000) prize. They were cited for work that has helped use antibody treatments that has increased the survival of patients with metastic melanoma. (AP Photo/Antonio Calanni)

Two U.S. scientists whose work has contributed to creating immunological treatments for cancer are among the winners of this year's Balzan Prizes, announced Monday, recognizing scholarly and scientific achievements.

James Allison of the University of Texas MD Anderson Cancer Center and Robert Schreiber of the Washington University School of Medicine were cited for their work on antibody treatments that has increased the survival of patients with metastatic melanoma.

The Balzan Foundation awards two prizes in the sciences and two in the humanities each year, rotating specialties to highlight new or emerging areas of research and sustain fields that might be overlooked elsewhere. Recipients receive 750,000 Swiss francs ($790,000), half of which must be used for research, preferably by young scholars or scientists.

Nobel Prize-winner Jules Hoffman, a presenter of the awards, said the work focusing on using the immune system to fight cancer, expanding from the traditional treatments of removal, radiation and chemotherapy, has already had success in 25 to 30 percent of melanoma patients in a study who had previously gone through the traditional battery of treatments. It is now being developed for small cell lung cancer and rectal cancer.

Other winners are:

—Belgian astrophysicist Michael Gillon for his work that has helped map new solar systems from the comfort of planet Earth, using robotic telescopes instead of much more costly satellites.

Thomas Maissen speaks to journalists during a press conference to present a 2017 Balzan's prize edition, in Milan, Italy, Monday, Sept. 11, 2017. James Allison of the University of Texas MD Anderson Cancer Center and Robert Schreiber of the Washington School of Medicine were announced Monday as winners of the 750,000 Swiss franc (660,000 euro, $790,000) prize. They were cited for work that has helped use antibody treatments that has increased the survival of patients with metastic melanoma. (AP Photo/Antonio Calanni)

—Germans Aleida and Jan Assmann, a married couple recognized for their work presenting collective memory "as a requirement for the formation of the identity of religious and political communities."

—Indian economist Bina Agarwal, a professor at the University of Manchester, recognized in the gender studies category for her "heroic" work studying women's contributions to agriculture in India.

—This year, the Balzan Foundation also awarded a fifth prize, in international relations, which was deferred from last year after the committee failed to reach agreement on a winner. It went to Robert O. Keohane of the Woodrow Wilson School at Princeton University, best known for his influential 1984 book "After Hegemony: Cooperation and Discord in the World Political Economy."

Prizes will be awarded in Bern, Switzerland, on Nov. 17.

Explore further: 1 Japanese, 2 Americans win Crafoord science prize

Related Stories

1 Japanese, 2 Americans win Crafoord science prize

January 12, 2017
A Japanese and two American scientists have been awarded the 2017 Crafoord Prize for fundamental discoveries in immune regulation.

Recommended for you

Alternative splicing, an important mechanism for cancer

September 22, 2017
Cancer, which is one of the leading causes of death worldwide, arises from the disruption of essential mechanisms of the normal cell life cycle, such as replication control, DNA repair and cell death. Thanks to the advances ...

'Labyrinth' chip could help monitor aggressive cancer stem cells

September 21, 2017
Inspired by the Labyrinth of Greek mythology, a new chip etched with fluid channels sends blood samples through a hydrodynamic maze to separate out rare circulating cancer cells into a relatively clean stream for analysis. ...

Whole food diet may help prevent colon cancer, other chronic conditions

September 21, 2017
A diet that includes plenty of colorful vegetables and fruits may contain compounds that can stop colon cancer and inflammatory bowel diseases in pigs, according to an international team of researchers. Understanding how ...

Drug combination may improve impact of immunotherapy in head and neck cancer

September 21, 2017
Checkpoint inhibitor-based immunotherapy has been shown to be very effective in recurrent and metastatic head and neck cancer but only in a minority of patients. University of California San Diego School of Medicine researchers ...

New kinase detection method helps identify targets for developing cancer drugs

September 21, 2017
Purdue University researchers have developed a high-throughput method for matching kinases to the proteins they phosphorylate, speeding the ability to identify multiple potential cancer drug targets.

Brain cancer growth halted by absence of protein, study finds

September 20, 2017
The growth of certain aggressive brain tumors can be halted by cutting off their access to a signaling molecule produced by the brain's nerve cells, according to a new study by researchers at the Stanford University School ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.